Tirzepatide and the risk of atherosclerotic cardiovascular events: population based cohort study

BMJ · Published 2026-08-05 · DOI 10.1136/bmj-2026-100011 · Cited by 1 (Crossref)

Authors (3)

Nils Krüger, Sebastian Schneeweiss, Shirley V Wang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2026

Citation

Krüger, N., Schneeweiss, S., Wang, S. (2026). Tirzepatide and the risk of atherosclerotic cardiovascular events: population based cohort study. BMJ. https://doi.org/10.1136/bmj-2026-100011

Related articles

Tirzepatide and cardiovascular outcomes · BMJ · 2026 · Cites or is cited by this article · Same journal
Medical colleges developing successor to axed NHS training scheme for overseas doctors · BMJ · 2026 · Same journal
Does Mounjaro cause hair loss? · BMJ · 2026 · Same journal
Palantir tool has not cut delayed discharges at NHS trusts, study finds · BMJ · 2026 · Same journal
Brain gain, waste, strain, and drain: international medical graduates after UK medical training legislation · BMJ · 2026 · Same journal
Four fifths of NHS trusts are still using pen and paper for record keeping, 25 years after first digitisation push · BMJ · 2026 · Same journal
Comparative effectiveness of azithromycin versus roflumilast in patients with chronic obstructive pulmonary disease: emulated target trial · BMJ · 2026 · Same journal
Ectopic pregnancy: Rise in admissions may be linked to deprivation, study suggests · BMJ · 2026 · Same journal
Fossil fuel industry has no place at climate COP · BMJ · 2026 · Same journal
Private equity involvement in UK healthcare · BMJ · 2026 · Same journal

Metrics

Citations (Crossref): 1